These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8024178)

  • 1. [Bolus of methylprednisolone in rheumatic practice].
    Renoux M; Hilliquin P; Menkès CJ
    Ann Med Interne (Paris); 1994; 145(2):133-9. PubMed ID: 8024178
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term experiences with local administration of Depo-Medrol (methylprednisolone acetate) in the treatment of various rheumatic diseases].
    Krampac I
    Reumatizam; 1975; 22(5):177-81. PubMed ID: 1105729
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of rheumatic diseases with methylprednisolone--mechanism of action and clinical applications].
    Buttgereit F
    Z Arztl Fortbild (Jena); 1994 Nov; 88(11):897-902. PubMed ID: 7839711
    [No Abstract]   [Full Text] [Related]  

  • 4. Intermediate-dose intramuscular methylprednisolone acetate in the treatment of rheumatic disease.
    Kovarsky J
    Ann Rheum Dis; 1983 Jun; 42(3):308-10. PubMed ID: 6602594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isaacs syndrome: clinical remission after methylprednisolone bolus].
    Elalaoui-Faris M; Ouahabi H; Slassi I; Medejel A; Ouazzani R; Saidi A; Miri A; Alaoui I; Chkili T
    Rev Neurol (Paris); 1993; 149(6-7):426-7. PubMed ID: 8303166
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pulse-therapy in rheumatology].
    Shilkina NP; Alekseev VI
    Ter Arkh; 1987; 59(4):115-9. PubMed ID: 3296283
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adverse effects of methylprednisolone pulse therapy].
    Nygaard H; Gran JT; Brath HK
    Tidsskr Nor Laegeforen; 1987 Jan; 107(1):31-2, 61. PubMed ID: 3493549
    [No Abstract]   [Full Text] [Related]  

  • 8. [Personal experiences of local use of methyl-prednisolone actetate in various rheumatic diseases].
    Budimir M; Mladenović M; Nikolić J
    Reumatizam; 1970; 17():15-9. PubMed ID: 5309822
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current aspects of glucocorticoid therapy of rheumatic diseases. Pulse-therapy].
    Solovyev SK; Ivanova MM
    Ter Arkh; 2009; 81(6):73-8. PubMed ID: 19663198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse methylprednisolone in rheumatoid arthritis.
    J Rheumatol; 1988 Oct; 15(10):1588-9. PubMed ID: 3204607
    [No Abstract]   [Full Text] [Related]  

  • 11. [A comparative evaluation of the efficacy of peroral and intravenous pulse therapy with methylprednisolone in rheumatic diseases].
    Amosova KM; Iaremenko OB; Potapkov OV; Ivashchenko NA
    Lik Sprava; 1998; (7):48-52. PubMed ID: 10050456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in circulating lymphocytes caused by methylprednisolone bolus].
    Le Quellec A
    Ann Med Interne (Paris); 1994 Jun; 145 Suppl 2():15-8. PubMed ID: 8074335
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of adverse effects of high-dose intravenous (pulse) methylprednisolone therapy in patients with rheumatic disease.
    Baethge BA; Lidsky MD; Goldberg JW
    Ann Pharmacother; 1992 Mar; 26(3):316-20. PubMed ID: 1554949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the pituitary-adrenal axis function following single intraarticular injection of methylprednisolone.
    Mader R; Lavi I; Luboshitzky R
    Arthritis Rheum; 2005 Mar; 52(3):924-8. PubMed ID: 15751089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral megadose methylprednisolone administration in hematologic disorders.
    Ozsoylu S
    Pediatr Hematol Oncol; 1994; 11(5):565, 563-4. PubMed ID: 7826852
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neurological sarcoidosis: demonstration of endoneural granuloma. Favorable course under bolus corticotherapy].
    Meyer C; Carre S; Hoel JC; Cadou B
    Ann Med Interne (Paris); 1991; 142(2):147-8. PubMed ID: 2064169
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous corticosteroids: adverse reactions are more variable than expected in children.
    Klein-Gitelman MS; Pachman LM
    J Rheumatol; 1998 Oct; 25(10):1995-2002. PubMed ID: 9779857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe coronary events and corticoids bolus. An update apropos of 3 new cases].
    Cerisier A; Dacosta A; Brulport V; Deluc D; Rousset H; Isaaz K
    Arch Mal Coeur Vaiss; 1997 Sep; 90(9):1285-8. PubMed ID: 9488776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two steroid preparations used to treat tennis elbow, using the hypospray.
    Clarke AK; Woodland J
    Rheumatol Rehabil; 1975 Feb; 14(1):47-9. PubMed ID: 1091959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypersensitivity to glucocorticoids: does it exist?
    Pizzuti P; Lioté F; Cerf-Payrastre I; Dryll A
    Rev Rhum Engl Ed; 1996 Mar; 63(3):223-6. PubMed ID: 8731243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.